Literature DB >> 8865203

Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation.

M Duenas1, I Torres-Aleman, F Naftolin, L M Garcia-Segura.   

Abstract

Neurotrophic effects of estradiol and insulin-like growth factor-I were assessed in primary cultures from fetal rat hypothalamus. Cultured neurons were immunostained with an antibody for the microtubule-associated protein-2. While both estradiol and insulin-like growth factor-I increased the number of microtubule-associated protein-2-immunoreactive neurons and the extension of immunoreactive processes, the effect of these two factors was not additive. The estradiol-induced increases in neuronal numbers and extension of neuronal processes were blocked by either the estrogen receptor antagonist ICI 182,780 or by an anti-sense oligonucleotide to the estrogen receptor. Furthermore, incubation of the cultures with an anti-sense oligonucleotide directed against the insulin-like growth factor-I messenger RNA also blocked the effect of estradiol. In turn, the effects of insulin-like growth factor-I were blocked by the estrogen receptor antagonist ICI 182,780 and by the anti-sense oligonucleotide to the estrogen receptor. These findings suggest that estradiol-induced activation of the estrogen receptor in developing hypothalamic cells requires the presence of insulin-like growth factor-I, and that both estradiol and insulin-like growth factor-I use the estrogen receptor as a mediator of their trophic effects on hypothalamic neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865203     DOI: 10.1016/0306-4522(96)00142-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

2.  Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Authors:  Wen-Fang Chen; Wai-Sum Lau; Pik-Yuen Cheung; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment.

Authors:  Cristina Pérez; Ana Navarro; Eva Martínez; Cristina Ordóñez; Eva Del Valle; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2011-07-15

4.  Fetal hypothalamic neuroprogenitor cell culture: preferential differentiation paths induced by leptin and insulin.

Authors:  Mina Desai; Tie Li; Michael G Ross
Journal:  Endocrinology       Date:  2011-06-07       Impact factor: 4.736

Review 5.  Sexual differentiation of the brain: genes, estrogen, and neurotrophic factors.

Authors:  Hugo F Carrer; María J Cambiasso
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

6.  Manganese induces IGF-1 and cyclooxygenase-2 gene expressions in the basal hypothalamus during prepubertal female development.

Authors:  Jill K Hiney; Vinod K Srivastava; William Les Dees
Journal:  Toxicol Sci       Date:  2011-03-14       Impact factor: 4.849

7.  Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.

Authors:  Li Xu; Wen-Fang Chen; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

8.  Insulin-like growth factor-I activates KiSS-1 gene expression in the brain of the prepubertal female rat.

Authors:  Jill K Hiney; Vinod K Srivastava; Michelle D Pine; W Les Dees
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

9.  Estrogen and brain vulnerability.

Authors:  Iñigo Azcoitia; Lydia L Doncarlos; Luis M Garcia-Segura
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

10.  Antagonism of brain insulin-like growth factor-1 receptors blocks estradiol effects on memory and levels of hippocampal synaptic proteins in ovariectomized rats.

Authors:  Britta S Nelson; Rachel C Springer; Jill M Daniel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.